Bove Mauro 4
4 · REGENERX BIOPHARMACEUTICALS INC · Filed Sep 6, 2017
Insider Transaction Report
Form 4
Bove Mauro
Director
Transactions
- Award
Stock Option (right to buy)
2017-09-01+125,000→ 125,000 totalExercise: $0.28Exp: 2027-09-01→ Common Stock (125,000 underlying)
Footnotes (1)
- [F1]The option vests in four equal annual installments beginning on September 1, 2017.